Physician profile
Jill C Lambert
NPI 1477615847
$1,251.41
in general payments reported to CMS, 2019-2025
13 companies · $87.06 in 2025
The $87.06 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $482 · 2023: $313 · 2024: $87.23 · 2025: $87.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $644.03 | 2021-2024 | |
| Hologic Sales and Service, LLC | $203.97 | 2022-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $145.19 | 2021-2025 | |
| Organon LLC | $96.58 | 2021-2023 | Nexplanon |
| Coopersurgical, INC. | $32.77 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $19.46 | 2021 | |
| Gynesonics, INC. | $18.64 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $18.07 | 2023 | Veozah |
| Therapeuticsmd, INC. | $16.20 | 2021 | |
| Merck Sharp & Dohme LLC | $15.04 | 2021 | |
| Avion Pharmaceuticals | $14.64 | 2023 | Balcoltra |
| Boston Scientific Corporation | $13.76 | 2022 | |
| Exeltis, USA INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.